Azar Seeks Deep Cuts to 340B Discounts; House Committee Clashes Over 340B Future HHS Secretary Alex Azar reportedly told a gathering of key lawmakers and staff late last week that the 340B drug discount to providers should be standardized to 20 percent, according to a report...

Executive Assistant Britnee supports Paul Lee, Senior Partner & Founder, as his executive assistant and office manager in the Washington, D.C. office. In addition to this, she also serves as the Internship Program Director for Strategic Health Care’s internship program. Britnee came to Strategic Healthcare in 2018 with...

Key House Panel Releases Eight Draft Bills To Change 340B The House Energy and Commerce Health Subcommittee will hold the long awaited 340B legislative hearing on Wednesday. 15 bills, including eight drafts, will be discussed reviewed. While witnesses have not been announced, it is expected the list will...

GAO: More Oversight Needed on 340B Contract Pharmacies; House 340B Hearing Mid-July In a new report for the House Energy and Commerce Committee, the Government Accountability Office suggests that HHS, and more specifically HRSA, should perform more oversight and more audits on 340B.. Most specifically, GAO...

340B Hospitals Denied Claims Appeals on Drug Payments In an effort to press a federal court decision to stop CMS' 340B payment cut,  hospital representatives sent a letter to the U.S. Court of Appeals detailing how two Medicare claims processors recently told hospitals that their appeals of...

Hospital Readmission Penalties Save $2 Billion,  MedPAC Suggests Expansion To All Conditions The Medicare Payment Advisory Commission released its annual June Report to Congress late last week and says the hospital readmission penalties program should be dramatically expanded.  The overall report examines a variety of Medicare...

The Cost of Health Care: a Renewed National Focus The high cost of pharmaceuticals may be the current national focus, but make no mistake, the overall high cost of health care in the United States is being targeted by the Trump Administration and Congress.  No one...

S&P: CMS' 340B Rule Could Hurt Many Hospitals; HRSA Delays Drug Company Penalties Standard and Poor says CMS cuts to 340B drugs could force smaller, rural, and high DSH covered entities to serve fewer patients and create a huge strain on emergency departments. The report states,...

House Plans To Take Up 70+ Opioid Bills Next Week While Congress is in its Memorial Day recess this week, congressional staff is putting together a package of bills to tackle the opioid crisis. The package encompasses over 70 bills that were approved by the House Energy...

Major Changes Coming to Pharmaceutical Pricing and Policy HHS Secretary Alex Azar and other Administration officials are beating the drum of pharmaceutical reform, promoting the President's "Blueprint for Lower Drug Prices" since it was introduced May 11th. Azar highlighted the need for Medicare to have the...